Delivery Order SPE2DR25D6028-SPE2DR26FASVU
Award Date 12/17/25
Potential Completion Date 12/18/25
Potential Value $2.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Quviviq 25 mg tablets in a quantity of 30s. This is a firm fixed price delivery order with a ceiling value of $1,662.22, representing a non-set-aside competitive award. The contract has an ultimate completion date of November 5, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Quviviq 25 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $2,712.98. This is a non-set-aside award, indicating the contract was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. The delivery order is a child contract under...
- The Defense Logistics Agency awarded a $2,274.96 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Quviviq 50 mg on November 25, 2025, with an ultimate completion date of November 26, 2025. The award is unclassified with no set-aside designation and represents a competitive award to the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $1,274.00 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Quviviq 50 mg tablets (30-count). This firm fixed price delivery order, with an ultimate completion date of July 29, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office...
- The Defense Logistics Agency awarded a $1,356.74 delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Quviviq 25 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with performance in Conshohocken, Pennsylvania, and a completion deadline of December 1, 2025. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global...
- The Defense Logistics Agency awarded a delivery order valued at $2,470.46 to AmerisourceBergen Drug Corp for the supply of Quviviq (25 mg tablets, 30-count packages) with a completion date of December 17, 2025. This competitive, non-set-aside award reflects a firm fixed price arrangement and represents a single pharmaceutical delivery under the company's broader federal medical supply portfolio. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a $3,846.82 delivery order to AmerisourceBergen Drug Corp for QUVIVIQ 50 mg tablets (30-count) on September 18, 2025, with an ultimate completion date of September 19, 2025. This is a firm fixed price, non-set-aside contract with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,212.55 for Quiviviq 25 mg tablets (30-count packages) on September 25, 2025, with an ultimate completion date of September 26, 2025. This is a firm fixed-price, non-set-aside contract to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under the company's existing contract vehicle with DLA. This...
- The Defense Logistics Agency awarded a $1,233.40 delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of QUVIVIQ 50MG tablets (30-count packaging). This is a firm fixed-price delivery order with an ultimate completion date of December 16, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued as a child contract under...
- The Defense Logistics Agency awarded a $1,614.22 delivery order to AmerisourceBergen Drug Corp for QUVIVIQ 50 mg tablets (30-count supply) on September 19, 2025, with completion targeted for September 22, 2025. This firm fixed-price delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract carries no set-aside designation and was competitively...